RARA CRAFT DATABASE for FDA Medical Devices
510(k)K203230

FDA DEVICE FACTS

Global Shoulder and Delta CTA systems

Depuy Lnc.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEApril 2, 2021PRODUCT CODEKWS

Indications for use

The DePuy GLOBAL ADVANTAGE Shoulder Systems is indicated for use in total or hemi-shoulder replacement for the treatment of: 1. A severely painful and/or disabled joint resulting from osteoarthritis, traumatic arthritis or rheumatoid arthritis; 2. Fracture-dislocations of the proximal humerus where the articular surface is severely comminuted, separated from its blood supply or where the surgeon's experience indicates that alternative methods of treatment are unsatisfactory; 3. Other difficult clinical problems where shoulder arthrodesis or resection arthroplasty are not acceptable ( e.g. revision of a failed primary component). The DePuy GLOBAL ADVANTAGE Shoulder System is also indicated for hemi-shoulder replacement for the treatment of: 1. Ununited humeral head fractures; 2. A vascular necrosis of the humeral head. GLOBAL ADVANTAGE CTA Humeral Heads The DePuy GLOBAL ADVANTAGE CTA Humeral Heads are indicated only for hemi-shoulder replacement in patients with rotator cuff tears. The DePuy GLOBAL ADVANTAGE CTA Humeral Heads can be used with the GLOBAL FX and GLOBAL ADVANTAGE Humeral Stems in hemi-shoulder replacement in patients with rotator cuff tears. GLOBAL ADVANTAGE Shoulder Systems Fixation Methods The DePuy GLOBAL ADVANTAGE Systems are indicated for the following fixation methods: POROCOATrM Porous-Coated Components - Porocoat porous-coated humeral stem prostheses are indicated for cemented or uncemented use with fixation provided by biological tissue ingrowth into the porous coating. Cemented Components - Humeral Stem and Glenoid components labeled "For cemented use only" are indicated only for use with bone cement. Press-fit or Cemented Components - Humeral stem prostheses without porous coating and labeled "For press-fit or cemented use only" are indicated for press-fit uncemented use or for use with bone cement.

The DePuy GLOBAL FX Shoulder System is indicated only for hemi-shoulder replacement for the treatment of: 1. A severely pai nful and/or disabled joint resulting from osteoarthritis, traumatic arthritis or rheumatoid arthritis; 2. Fracture-dislocations of the proximal humerus where the articular surface is severely comminuted, separated from its blood supply or where the surgeon's experience indicates that alternative methods of treatment are unsatisfactory; 3. Other difficult clinical problems where shoulder arthrodesis or resection arthroplasty are not acceptable ( e.g. revision of a failed primary component); 4. Ununited humeral head fractures; 5. A vascular necrosis of the humeral head. GLOBAL FX Shoulder Systems Fixation Methods The DePuy GLOBAL FX Shoulder System is indicated for the following fixation methods:

• POROCOAT™ Porous-Coated Components - Porocoat porous-coated humeral stem prostheses are indicated for cemented or uncemented use with fixation provided by biological tissue ingrowth into the porous coating.

• Cemented Components - Humeral Stem and Glenoid components labeled “For cemented use only” are indicated only for use with bone cement.

• Press-fit or Cemented Components - Humeral stem prostheses without porous coating and labeled “For press-fit or cemented use only” are indicated for press-fit uncemented use or for use with bone cement.

GLOBAL™ CAP The DePuy GLOBAL™ CAP Resurfacing Shoulder Humeral Heads are intended as a total or hemi-shoulder replacement in patients where the humeral head and neck are of sufficient bone stock and the rotator cuff is intact or reconstructable. This device is designed to increase shoulder mobility by: reducing pain; restoring alignment; restoring flexion and extension movement; and resisting dislocation. The DePuy GLOBAL™ CAP Resurfacing Shoulder Humeral Heads are indicated for use as a replacement of shoulder joints disabled by rheumatoid arthritis with pain, non-inflammatory degenerative joint disease (i.e. osteoarthritis and avascular necrosis), deformity and/or limited motion, fractures of the humeral head and traumatic arthritis. The DePuy GLOBAL™ CAP Resurfacing Shoulder Humeral Heads are intended for uncemented use only. GLOBAL™ CAP CTA™ The DePuy GLOBAL ™ CAP CTA R esurfacing Shoulder is indicated only for hemi-shoulder replacement in patients with rotator cuff tears and arthritis. Specific indications include: 1. Rotator cuff tear arthropathy. 2. Difficult clinical management problems where other methods of treatment may not be suitable or may be inadequate. The DePuy GLOBAL ™ CAP CTA Resurfacing Shoulder Humeral Heads are intended for uncemented use only.

The Glenoid is intended for use in total shoulder replacement surgery for patients suffering from: 1. A severely painful and/or disabled joint resulting from osteoarthritis, traumatic arthritis or rheumatoid arthritis 2. Fracture-dislocations of the proximal humerus where the articular surface is severely communited, separated from its blood supply or where the surgeon's experience indicates that alternative methods of treatment are unsatisfactory. 3. Other difficult clinical problems where shoulder arthrodesis or resection arthroplasty are not acceptable ( e.g revision of a failed primary component). Glenoid components are intended for cemented use only.

The DePuy GLOBAL AP Shoulder System is indicated for use in total or hemi-shoulder replacement for the treatment of: 1. A severely painful and/or disabled joint resulting from osteoarthritis, traumatic arthritis or rheumatoid arthritis; 2. Fracture-dislocations of the proximal humerus where the articular surface is severely comminuted, separated from its blood supply or where the surgeon's experience indicates that alternative methods of treatment are unsatisfactory; 3. Other difficult clinical problems where shoulder arthrodesis or resection arthroplasty are not acceptable ( e.g. revision of a failed primary component). The DePuy GLOBAL AP Shoulder Systems is also indicated for hemi-shoulder replacement for the treatment of: 1. Ununited humeral head fractures; 2. A vascular necrosis of the humeral head. GLOBAL AP™ CTA Humeral Heads The DePuy GLOBAL AP CTA Humeral Heads are indicated only for hemi-shoulder replacement in patients with rotator cuff tears. The GLOBAL AP CTA Humeral Head can be used with the GLOBAL AP Humeral Stem in hemi-shoulder replacement in patients with rotator cuff tears. GLOBAL AP™ Shoulder Systems Fixation Methods. The DePuy GLOBAL AP Shoulder Systems are indicated for the following fixation methods: POROCOATrM Porous-Coated Components - Porocoat porous-coated humeral stem prostheses are indicated for cemented or uncemented use with fixation provided by biological tissue ingrowth into the porous coating. Cemented Components - Humeral Stem and Glenoid components labeled "For cemented use only" are indicated only for use with bone cement. Press-fit or Cemented Components - Humeral stem prostheses without porous coating and labeled "For press-fit or cemented use only" are indicated for press-fit uncemented use or for use with bone cement.

The StepTech Anchor Peg Glenoid is intended for use in total shoulder replacement surgery for patients suffering from: 1. A severely painful and/or disabled joint resulting from osteoarthritis, traumatic arthritis or rheumatoid arthritis 2. Fracture-dislocations of the proximal humerus where the articular surface is severely communited, separated from its blood supply or where the surgeon's experience indicates that alternative methods of treatment are unsatisfactory. 3. Other difficult clinical problems where shoulder arthrodesis or resection arthroplasty are not acceptable ( e.g revision of a failed primary component). Glenoid components are intended for cemented use only.

The Glenoid is intended for use in total shoulder replacement surgery for patients suffering from: 1. A severely painful and/or disabled joint resulting from osteoarthritis, traumatic arthritis or rheumatoid arthritis 2. Fracture-dislocations of the proximal humerus where the articular surfaces are severely communited, separated from its blood supply or where the surgeon's experience indicates that alternative methods of treatment are unsatisfactory. 3. Other difficult clinical problems where shoulder arthrodesis or resection arthroplasty are not acceptable ( e.g. revision of a failed primary component). Glenoid components are intended for cemented use only.

The DEL TA CTA TM Reverse Shoulder Prosthesis is indicated for use in: Form Approved: 0MB No. 0910-0120 Expiration Date: 06/30/2020 See PRA Statement below. 1. Grossly rotator cuff deficient joint with severe arthropathy or a previous failed joint replacement with a grossly rotator cuff deficient joint. 2. The DEL TA CTA TM hemi-shoulder replacement is also indicated for hemi-arthroplasty if the glenoid is fractured intraoperatively or for revision surgery in cases with insufficient glenoid bone stock. 3. The patient's joint must be anatomically and structurally suited to receive the selected implant(s), and a functional Deltoid muscle is necessary to use the device. For US use only: All components are intended for cemented use only

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 23, 2026